Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marie Dupret

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Current Medicinal Chemistry|February 23, 2005
Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferasesJean-Marie Dupret, Fernando Rodrigues-Lima
Current Pharmaceutical Design|August 24, 2004
Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: role of genetic and non genetic factorsFernando Rodrigues-Lima, Jean-Marie Dupret
Biochemical and Biophysical Research Communications|June 11, 2002
In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteriaFernando Rodrigues-Lima, Jean-Marie Dupret
Biochemical and Biophysical Research Communications|February 7, 2002
3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loopFernando Rodrigues-Lima, Jean-Marie Dupret
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Renal cell carcinoma and environmental factors]Sandrine Longuemaux, Fernando Rodrigues-Lima, Jean-Marie Dupret
Current Drug Metabolism|August 6, 2008
Effect of environmental substances on the activity of arylamine N-acetyltransferasesFernando Rodrigues-Lima, Julien Dairou, Jean-Marie Dupret
The FEBS Journal|October 27, 2016
The structure of brain glycogen phosphorylase-from allosteric regulation mechanisms to clinical perspectivesCécile Mathieu, Jean-Marie Dupret, Fernando Rodrigues Lima
FEBS Letters|August 16, 2005
Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cellsJulien Dairou, Jean-Marie Dupret, Fernando Rodrigues-Lima
Advances in Neurobiology|November 1, 2019
The Structure and the Regulation of Glycogen Phosphorylases in BrainCécile Mathieu, Jean-Marie Dupret, Fernando Rodrigues-Lima
Current Drug Targets|January 1, 2010
Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?Fernando Rodrigues-Lima, Julien Dairou, Florent Busi, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Current Medicinal Chemistry|February 23, 2005
Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferasesJean-Marie Dupret, Fernando Rodrigues-Lima
Current Pharmaceutical Design|August 24, 2004
Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: role of genetic and non genetic factorsFernando Rodrigues-Lima, Jean-Marie Dupret
Biochemical and Biophysical Research Communications|June 11, 2002
In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteriaFernando Rodrigues-Lima, Jean-Marie Dupret
Biochemical and Biophysical Research Communications|February 7, 2002
3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loopFernando Rodrigues-Lima, Jean-Marie Dupret
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Renal cell carcinoma and environmental factors]Sandrine Longuemaux, Fernando Rodrigues-Lima, Jean-Marie Dupret
Current Drug Metabolism|August 6, 2008
Effect of environmental substances on the activity of arylamine N-acetyltransferasesFernando Rodrigues-Lima, Julien Dairou, Jean-Marie Dupret
The FEBS Journal|October 27, 2016
The structure of brain glycogen phosphorylase-from allosteric regulation mechanisms to clinical perspectivesCécile Mathieu, Jean-Marie Dupret, Fernando Rodrigues Lima
FEBS Letters|August 16, 2005
Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cellsJulien Dairou, Jean-Marie Dupret, Fernando Rodrigues-Lima
Advances in Neurobiology|November 1, 2019
The Structure and the Regulation of Glycogen Phosphorylases in BrainCécile Mathieu, Jean-Marie Dupret, Fernando Rodrigues-Lima
Current Drug Targets|January 1, 2010
Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?Fernando Rodrigues-Lima, Julien Dairou, Florent Busi, et al.
Pageof 8